文献速递创伤骨科运动医学关节外科

氨甲环酸减缓小鼠创伤后骨关节炎的进展

Tranexamic Acid Attenuates the Progression of Posttraumatic Osteoarthritis in Mice.
PubMed 文献 · Am J Sports Med · 2024-02-02

本研究在小鼠前交叉韧带切断诱导的创伤后骨关节炎模型中,评估全身与局部氨甲环酸治疗的效果;结果显示两种给药方式均显著减轻软骨退变、滑膜炎和骨侵蚀评分并提高透明软骨与钙化软骨厚度比,全身给药还逆转软骨下骨丢失和骨赘形成。

要点

  • 全身和局部氨甲环酸均显著减轻创伤后骨关节炎小鼠的软骨退变、滑膜炎和骨侵蚀评分。
  • 全身氨甲环酸逆转前交叉韧带切断诱导的软骨下骨丢失和骨赘形成,局部治疗无此效果。
  • 全身氨甲环酸减少破骨细胞数量和表面积,对成骨细胞无影响;局部治疗对两者均无影响。

核心结论

  • 全身和局部氨甲环酸均对创伤后骨关节炎的进展发挥保护作用,氨甲环酸药物重定位可能有助于预防或治疗创伤后骨关节炎,尤其在前交叉韧带术后。

研究设计与样本

  • 对照实验室研究,采用雌性小鼠右侧膝关节前交叉韧带切断诱导骨关节炎,自手术当日起分别每日腹腔注射或每周关节腔内注射氨甲环酸或溶媒,持续4周。

主要发现

  • 全身和局部氨甲环酸治疗均显著降低软骨退变、滑膜炎和骨侵蚀评分,并提高透明软骨与钙化软骨厚度比。
  • 全身氨甲环酸逆转前交叉韧带切断诱导的软骨下骨丢失和骨赘形成,而局部治疗无此效果。
  • 全身氨甲环酸减少破骨细胞数量和表面积,成骨细胞数量和表面积未受影响;局部氨甲环酸对破骨细胞或成骨细胞参数均无影响。

临床怎么用

  • 作者认为氨甲环酸药物重定位可能有助于预防或治疗创伤后骨关节炎,尤其在前交叉韧带术后;氨甲环酸可能对膝关节创伤后骨关节炎患者有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Posttraumatic osteoarthritis (OA) is a common disorder associated with a high socioeconomic burden, particularly in young, physically active, and working patients. Tranexamic acid (TXA) is commonly used in orthopaedic trauma surgery as an antifibrinolytic agent to control excessive bleeding. Previous studies have reported that TXA modulates inflammation and bone cell function, both of which are dysregulated during posttraumatic OA disease progression. PURPOSE: To evaluate the therapeutic effects of systemic and topical TXA treatment on the progression of posttraumatic OA in the knee of mice. STUDY DESIGN: Controlled laboratory study. METHODS: OA was induced via anterior cruciate ligament (ACL) transection on the right knee of female mice. Mice were treated with TXA or vehicle intraperitoneally daily or intra-articularly weekly for 4 weeks, starting on the day of surgery. Articular cartilage degeneration, synovitis, bone erosion, and osteophyte formation were scored histologically. Micro-computed tomography evaluation was conducted to measure the subchondral bone microstructure and osteophyte volume. Cartilage thickness and bone remodeling were assessed histomorphometrically. RESULTS: Both systemic and topical TXA treatment significantly reduced cartilage degeneration, synovitis, and bone erosion scores and increased the ratio of hyaline to calcified cartilage thickness in posttraumatic OA. Systemic TXA reversed ACL transection-induced subchondral bone loss and osteophyte formation, whereas topical treatment had no effect. Systemic TXA decreased the number and surface area of osteoclasts, whereas those of osteoblasts were not affected. No effect of topical TXA on osteoblast or osteoclast parameters was observed. CONCLUSION: Both systemic and topical TXA exerted protective effects on the progression of posttraumatic OA. Drug repurposing of TXA may, therefore, be useful for the prevention or treatment of posttraumatic OA, particularly after ACL surgery. CLINICAL RELEVANCE: TXA might be beneficial in patients with posttraumatic OA of the knee.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Xie W, Jiang S, Donat A, et al. Tranexamic Acid Attenuates the Progression of Posttraumatic Osteoarthritis in Mice. Am J Sports Med. 2024. PMID: 38305280. doi:10.1177/03635465231220855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。